Evotec SE (EVO) stock
EVONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as EVOTF
$1.58−0.08 (-4.82%)
Close on Nov 13, 2026Market cap $561.78MP/E –Yield –
Evotec cash
Cash and short-term investments held at the end of each period.
Evotec's cash was €418.52M at Dec 31, 2025. For fiscal 2025 it was €418.52M, up 36.6% from the year before. The highest annual figure on record is €699.33M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €418.52M | +36.6% |
| FY2024 | Dec 31, 2024 | €306.39M | -40.0% |
| FY2023 | Dec 31, 2023 | €510.91M | +23.1% |
| FY2022 | Dec 31, 2022 | €415.16M | -40.6% |
| FY2021 | Dec 31, 2021 | €699.33M | +65.5% |
| FY2020 | Dec 31, 2020 | €422.58M | +52.5% |
| FY2019 | Dec 31, 2019 | €277.03M | +154.0% |
| FY2018 | Dec 31, 2018 | €109.06M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | €418.52M | -40.2% |
| Q4 FY2024 | Dec 31, 2024 | €306.39M | -27.5% |
| Q4 FY2023 | Dec 31, 2023 | €510.91M | +84.4% |
| Q4 FY2022 | Dec 31, 2022 | €415.16M | +280.7% |
| Q4 FY2021 | Dec 31, 2021 | €699.33M | – |
| Q4 FY2020 | Dec 31, 2020 | €422.58M | – |
| Q4 FY2019 | Dec 31, 2019 | €277.03M | – |
| Q4 FY2018 | Dec 31, 2018 | €109.06M | – |
See a number that looks wrong?